Scale Up

Jun 02, 2008
BioPharm International
With a variety of recombinant, animal-free, defined protein supplements such as growth factors, transferrin, and albumin entering the market, the biopharmaceutical industry now has innovative and safer alternatives to serum and other animal-derived supplements.
Jun 02, 2008
BioPharm International
A discussion of past achievements and future expectations of recombinant protein production yields from mammalian cells.
Jun 01, 2008
BioPharm International
Process-modeling tools can ensure smooth tech transfer.
May 01, 2008
BioPharm International
By BioPharm International Editors
A comparison of primary harvest techniques.
Apr 01, 2008
BioPharm International
Disposable technologies that mimic the conventional stainless-steel bioreactor will be most readily adopted
Mar 02, 2008
BioPharm International
When platform processes are applied to fusion molecules, innovation and flexibility are needed.
Mar 02, 2008
BioPharm International
If certain engineering challenges can be addressed, precipitation may prove to be a valuable tool for antibody purification.
Mar 02, 2008
BioPharm International
The future of therapeutic MAbs lies in the development of economically feasible downstream processes.
Mar 02, 2008
BioPharm International
An alternative approach to traditional Protein A schemes is comparable in overall efficiency, product recovery, and quality.
Mar 02, 2008
BioPharm International
Manufacturing challenges surround the use of IgM monoclonal antibodies, but these can be overcome with current technology.
native1_300x100
lorem ipsum